June 18, 2019- Designing Clinical Trials From the Patient’s Point of View
As leaders in biotech and life science industry, we strive to bring the most innovative treatments to the bedside. As professionals in clinical research, we strive to provide the best quality service and data to support life-changing studies. Clinical trends have forecasted methods to run trials more efficiently, as protocols become more complex. Throughout these changes, how do we keep the study patient focused?
Join Biocom’s CRO group as we host a discussion with patient advocacy groups on designing patient-centric studies. The event will highlight the current trends and new opportunities that both the biotech and clinical industry may adapt to lessen the burden of patient participation, increase patient enrollment and retention, and set the example as an industry that is truly putting their key customers, the patients, first .
Katie Croskrey – Executive Director, Alzheimer’s Association
Josh Bohannan – Public Policy Manager, Alzheimer’s Association
Tracy Dixon-Salazar, PhD - Director of Research & Strategy, LGS Foundation (Lennox-Gastaut Syndrome)